Your browser doesn't support javascript.
loading
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.
Krintel, S B; Dehlendorff, C; Hetland, M L; Hørslev-Petersen, K; Andersen, K K; Junker, P; Pødenphant, J; Ellingsen, T; Ahlquist, P; Lindegaard, H M; Linauskas, A; Schlemmer, A; Dam, M Y; Hansen, I; Horn, H C; Jørgensen, A; Raun, J; Ammitzbøll, C G; Østergaard, M; Stengaard-Pedersen, K; Johansen, J S.
Afiliação
  • Krintel SB; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital at Glostrup, Glostrup, Denmark.
  • Dehlendorff C; Department of Medicine, Copenhagen University Hospital at Herlev, Copenhagen, Denmark.
  • Hetland ML; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
  • Hørslev-Petersen K; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital at Glostrup, Glostrup, Denmark.
  • Andersen KK; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Junker P; King Christian 10th Hospital for Rheumatic Diseases, University of Southern Denmark, Graasten, Denmark.
  • Pødenphant J; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
  • Ellingsen T; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
  • Ahlquist P; Department of Rheumatology, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark.
  • Lindegaard HM; Diagnostic Centre, Regional Hospital Silkeborg, Silkeborg, Denmark.
  • Linauskas A; Department of Rheumatology, Vejle Hospital, Vejle, Denmark.
  • Schlemmer A; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
  • Dam MY; Department of Rheumatology, Vendsyssel Hospital, Hjørring, Denmark.
  • Hansen I; Department of Rheumatology, Aalborg Hospital, Aalborg, Denmark.
  • Horn HC; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Jørgensen A; Department of Rheumatology, Viborg Hospital, Viborg, Denmark.
  • Raun J; Department of Rheumatology, Vejle Hospital, Vejle, Denmark.
  • Ammitzbøll CG; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Østergaard M; King Christian 10th Hospital for Rheumatic Diseases, University of Southern Denmark, Graasten, Denmark.
  • Stengaard-Pedersen K; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Johansen JS; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital at Glostrup, Glostrup, Denmark.
Pharmacogenomics J ; 16(2): 141-6, 2016 Apr.
Article em En | MEDLINE | ID: mdl-25939484
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Antirreumáticos / MicroRNAs / Adalimumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Antirreumáticos / MicroRNAs / Adalimumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article